Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Sales (2020 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Return on Sales for 6 consecutive years, with 0.05% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 77.0% year-over-year to 0.05%, compared with a TTM value of 0.17% through Sep 2025, down 15.0%, and an annual FY2024 reading of 0.01%, up 75.0% over the prior year.
  • Return on Sales was 0.05% for Q3 2025 at Fennec Pharmaceuticals, up from 0.33% in the prior quarter.
  • Across five years, Return on Sales topped out at 1816.14% in Q3 2022 and bottomed at 94.54% in Q1 2021.
  • Average Return on Sales over 5 years is 176.54%, with a median of 0.23% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 189671bps in 2022, then tumbled -181641bps in 2023.
  • Year by year, Return on Sales stood at 80.57% in 2021, then surged by 109bps to 7.54% in 2022, then tumbled by -104bps to 0.27% in 2023, then grew by 30bps to 0.19% in 2024, then skyrocketed by 74bps to 0.05% in 2025.
  • Business Quant data shows Return on Sales for FENC at 0.05% in Q3 2025, 0.33% in Q2 2025, and 0.13% in Q1 2025.